These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 22069469

  • 1. Platelets retain high levels of active plasminogen activator inhibitor 1.
    Brogren H, Wallmark K, Deinum J, Karlsson L, Jern S.
    PLoS One; 2011; 6(11):e26762. PubMed ID: 22069469
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR, Sobel BE.
    Thromb Res; 1993 Dec 01; 72(5):413-21. PubMed ID: 8303684
    [Abstract] [Full Text] [Related]

  • 3. Platelets synthesize large amounts of active plasminogen activator inhibitor 1.
    Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, Jern S.
    Blood; 2004 Dec 15; 104(13):3943-8. PubMed ID: 15315974
    [Abstract] [Full Text] [Related]

  • 4. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
    Yasui H, Suzuki Y, Sano H, Suda T, Chida K, Dan T, Miyata T, Urano T.
    Thromb Res; 2013 Jul 15; 132(1):100-5. PubMed ID: 23611258
    [Abstract] [Full Text] [Related]

  • 5. Demonstration of a functionally active tPA-like plasminogen activator in human platelets.
    Wang DL, Pan YT, Wang JJ, Cheng CH, Liu CY.
    Thromb Haemost; 1994 Apr 15; 71(4):493-8. PubMed ID: 8052969
    [Abstract] [Full Text] [Related]

  • 6. Thrombin Provokes Degranulation of Platelet α-Granules Leading to the Release of Active Plasminogen Activator Inhibitor-1 (PAI-1).
    Huebner BR, Moore EE, Moore HB, Stettler GR, Nunns GR, Lawson P, Sauaia A, Kelher M, Banerjee A, Silliman CC.
    Shock; 2018 Dec 15; 50(6):671-676. PubMed ID: 29280928
    [Abstract] [Full Text] [Related]

  • 7. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
    Urano T, Suzuki Y, Iwaki T, Sano H, Honkura N, Castellino FJ.
    Curr Drug Targets; 2019 Dec 15; 20(16):1695-1701. PubMed ID: 31309890
    [Abstract] [Full Text] [Related]

  • 8. The significance of fibrin binding by plasminogen activator inhibitor 1 for the mechanism of tissue-type plasminogen activator-mediated fibrinolysis.
    Stringer HA, Pannekoek H.
    J Biol Chem; 1995 May 12; 270(19):11205-8. PubMed ID: 7744752
    [Abstract] [Full Text] [Related]

  • 9. Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation.
    Morrow GB, Whyte CS, Mutch NJ.
    Haematologica; 2020 Dec 01; 105(12):2824-2833. PubMed ID: 33256381
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of the platelet pool of Plasminogen Activator Inhibitor-1 in well-controlled type 2 diabetes patients.
    Mossberg K, Olausson J, Fryk E, Jern S, Jansson PA, Brogren H.
    PLoS One; 2022 Dec 01; 17(8):e0267833. PubMed ID: 36044519
    [Abstract] [Full Text] [Related]

  • 13. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA, Booth NA, Croll AM, Bennett B.
    Thromb Haemost; 1993 Aug 02; 70(2):301-6. PubMed ID: 8236139
    [Abstract] [Full Text] [Related]

  • 14. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J, Aleem AM, Selman SH, Skrzypczak-Jankun E, Lysiak-Szydlowska W, Grafos N, Fryer HJ, Greenfield RS.
    Int J Mol Med; 2007 Nov 02; 20(5):683-7. PubMed ID: 17912461
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.
    Stringer HA, van Swieten P, Heijnen HF, Sixma JJ, Pannekoek H.
    Arterioscler Thromb; 1994 Sep 02; 14(9):1452-8. PubMed ID: 8068607
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.
    Olson ST, Swanson R, Day D, Verhamme I, Kvassman J, Shore JD.
    Biochemistry; 2001 Oct 02; 40(39):11742-56. PubMed ID: 11570875
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.